Picture of Heron Therapeutics logo

HRTX — Heron Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Heron Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

* Heron Therapeutics Inc  HRTX.OQ   HRTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 12
for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report a
3.2% increase in revenue to $30.975 million from $30.03 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.The company's guidance on November 14 2023,
for the period ended December 31, was for revenue between $30.00
million and $32.00 million.
    * ​LSEG's mean analyst estimate for Heron Therapeutics Inc
is for
a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Heron
Therapeutics Inc is $7.00​, above​ its last closing price
of $2.59. ​​​

The company's guidance on November 14 2023 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 30 million and -6
million (USD).The company's guidance on November 14 2023 for the
period ended December 31 was for gross profit margin of USD62%.
Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.29       -0.29      -0.17     Beat    41.9
 Jun. 30 2023  -0.23       -0.23      -0.35     Missed  -50
 Mar. 31 2023  -0.21       -0.20      -0.27     Missed  -33​
 Dec. 31 2022  -0.30       -0.28      -0.17     Beat    40.4
 ​​Sep.        -0.38       -0.38      -0.38     Met     -1.1
 30 2022                                                
 Jun. 30 2022  -0.53       -0.50      -0.55     Missed  -8.9​
 Mar. 31 2022  -0.49       -0.48      -0.63     Missed  -32.4
 Dec. 31 2021  -0.58       -0.58      -0.54     Beat    6.3
 This summary was machine generated March 8 at 21:48 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Heron Therapeutics

See all news